Staphylococcus aureus is a gram-positive bacterium responsible for a broad range of clinical diseases. It has become notorious for causing infections in both hospitals and the community (
1). Chronic biofilm-related infections triggered by
S. aureus predominantly drive major increases in morbidity and mortality, notably when linked with medical devices (
2). Accordingly, many studies have been conducted to understand the molecular basis affecting
S. aureus biofilm formation and the mechanisms of antibiotic resistance (
3). Treatment has become challenging due to the emergence of multidrug-resistant strains (
4). One strategy to suppress the drug resistance of biofilms is to exploit new drug delivery technologies (
5). Recently, many attempts have been made to use nanoparticles as carriers due to their unique behavior (
6,
7). Additionally, these systems are suitable for the delivery of natural materials (
8). These nano-engineered technologies, with their outstanding properties, enable them to overcome hurdles faced by conventional antimicrobials and, with appropriate formulation, can be considered drug delivery agents to biofilms (
9). Lipid-based nanocarriers such as solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have been developed, indicating improved properties such as increased drug loading capacity and physical stability (
10). These nanocarriers aim to overcome the limitations of other colloidal carriers, including emulsions, liposomes, and polymeric nanoparticles (
11,
12). Piperine, the main bioactive constituent of black pepper, exhibits a plethora of beneficial effects, including antioxidant, anti-tumor, anti-inflammatory, anti-anxiety, liver-protective, anti-depression, and antibacterial effects (
13). However, its therapeutic application is limited by poor solubility and bioavailability. Consequently, various formulation strategies with different techniques have been exploited to improve piperine's physicochemical, pharmacokinetic, and pharmacodynamic properties (
14). Recent investigations show that nanoencapsulation and nanoparticles of piperine products enhance the bioavailability of piperine through local and oral administration (
15). The antibacterial activity of black pepper against gram-positive bacteria, such as
S. aureus, reported by some studies, corroborates that this spice can be a powerful agent against infectious diseases and pathogens caused by this microorganism (
16,
17). Meanwhile, liquid lipids, as an essential component of NLCs, should be examined to achieve possible synergistic performance. Liquid lipids are composed of fatty acids, triglycerides, monoglycerides, etc., and oils of natural sources extracted from various sources with therapeutic properties can be loaded into the matrix of NLCs (
18,
19). Lavender
(Lavandula spp.) is recognized as one of the medicinal plants for stress control and belongs to the Lamiaceae family (
20). Lavender essential oil comprises several antimicrobial substances, such as eucalyptol, linalool, terpinen-4-ol, and α-terpineol (
21), with linalool being the potent active ingredient against a broad range of microorganisms (
21). It has been revealed that lavender oil has effective performance on species of bacteria that are even resistant to antibiotics, such as methicillin-resistant
S. aureus (MRSA), vancomycin-resistant
Enterococcus (VRE),
Escherichia coli,
Pseudomonas aeruginosa, and
Propionibacterium acnes (
22). Various investigations have elucidated the presence of a moderate synergistic effect between essential oils and pharmaceutical agents, notably antibiotics, which is predominantly attributable to the membrane interactions of the constituents of essential oils; in this regard, essential oils present a compelling alternative for mitigating antibiotic utilization (
23). Considering that no piperine/lavender oil combination has been reported to date, the aim of this study was to examine in vitro interactions between lavender oil encapsulated within NLCs and piperine.